Suvina Amin
About Suvina Amin
Suvina Amin is the Director of Worldwide HEOR, Hematology at Bristol Myers Squibb, with over 9 years of experience in Health Economics and Outcomes Research.
Title
Suvina Amin holds the position of Director, Worldwide HEOR, Hematology at Bristol Myers Squibb. Her work focuses on health economics and outcomes research within the hematology field.
Company
Suvina Amin is currently employed at Bristol Myers Squibb, a global biopharmaceutical company, where she serves as Director, Worldwide HEOR, Hematology, based in New Jersey, United States.
Education and Expertise
Suvina Amin obtained her Doctorate of Public Health (DrPH) in Global Health Leadership from Indiana University–Purdue University Indianapolis. She holds a Masters of Public Health (MPH) in Epidemiology & Biostatistics - International Health from the University of York and a Bachelor of Science (B.Sc.) in Biology from the University of Ottawa.
Professional Background
Suvina Amin has gained substantial experience in the fields of Health Economics and Outcomes Research (HEOR) and Health Technology Assessment (HTA). Before her current role, she served as Global RWE Strategy Tumor Lead, Oncology at AstraZeneca from 2016 to 2021. Prior to this, she held positions in various organizations, including JDRF Canada, CADTH, and Cancer Care Ontario, and roles such as Research Grants Specialist, Clinical Research Officer, and Epidemiology Research Associate.
HEOR and Product Launch Expertise
With over nine years of experience, Suvina Amin has a robust background in conducting and disseminating HEOR. She has participated in product launches across multiple therapeutic areas including Respiratory, Oncology, and Pediatric Rare Disease. Her expertise also extends to working with external alliance partnerships and developing Health Technology Assessment strategies.